Abstract:ConspectusClustered, regularly interspaced, short palindromic repeat (CRISPR)/associated protein 9 (CRISPR/Cas9) is emerging as a powerful genome-editing tool, enabling precise and targeted modifications of virtually any genomic sequence in living cells. These technologies have potential therapeutic applications for cancers, metabolic diseases, and genetic disorders. However, several major challenges hinder the full realization of their potential. Specifically, CRISPR-Cas9 gene editors, whether delivered as plasmid DNA, mRNA/sgRNA, or ribonucleoprotein (RNP), exhibit poor membrane permeability, restricting their access to the intracellular genome, where the editing occurs. Additionally, these editors lack tissue or organ specificity, raising concerns about off-target editing at the tissue level that causes unwanted genotoxicity. Though a range of delivery carriers has been developed to deliver Cas9 editors, their effectiveness is often limited by a number of barriers at both the extracellular and intracellular levels. Moreover, the prolonged activity of Cas9 increases the risk of off-target editing at the genomic level. Therefore, it is crucial to develop efficient delivery vectors, along with molecular switches to safely regulate Cas9 activity.In this Account, we summarize our recent achievements in developing different types of materials that can efficiently deliver the plasmid DNA encoding Cas9 protein and single-guide RNA (sgRNA), or Cas9 RNP into cells to highlight the design considerations of carriers for safe and efficient delivery in vitro and in vivo. After elucidating the chemical and physical factors that are responsible for encapsulating and delivering these biomacromolecules, we further elucidate how we design the biodegradable polymeric carriers using dynamic disulfide chemistry, emphasize their safe and efficient delivery features for genome-editing biomacromolecules, and also introduce the integration of the intracellular delivery of genome-editing biomacromolecules with microneedle-based transdermal delivery to promote therapeutic genome editing for inflammatory skin disorders. Finally, we review how we exploit optical, chemical, and genetic switches to control the Cas9 activity in conjunction with targeted delivery to address the spatiotemporal specificity of gene editing in vivo and demonstrate their precision therapy against cancer and colitis treatment as proof-of-concept examples. In the final part, we will summarize the progress we have made and propose the future directions that may impact the field based on our own research outcomes.

Lipid, Inorganic, Polymer, and DNA Based Nanocarriers for Delivery of CRISPR/Cas9 System

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

Development of Delivery Strategies for CRISPR‐Cas9 Genome Editing

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing

Active Delivery of CRISPR System Using Targetable or Controllable Nanocarriers

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9

Key Considerations in Designing CRISPR/Cas9-carrying Nanoparticles for Therapeutic Genome Editing.

DNA Nanomaterials for Delivery of Clustered Regularly Interspaced Short Palindromic Repeats/Cas Systems

Key Considerations In Designing Crispr/Cas9-Carrying Nanoparticles For Therapeutic Genome Editing

Latest Progress in the Study of Nanoparticle-Based Delivery of the CRISPR/Cas9 System.

Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

Material Solutions for Delivery of CRISPR/Cas-based Genome Editing Tools: Current Status and Future Outlook

Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing

Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing

Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics

Intelligent nanotherapeutic strategies for the delivery of CRISPR system

Nano-vectors for CRISPR/Cas9-mediated genome editing

Progress of delivery methods for CRISPR-Cas9

Liposome-Based Carriers for CRISPR Genome Editing

Tailoring Non-Viral Delivery Vehicles for Transporting Genome-Editing Tools